We used Diffuse Reflectance spectroscopy (DRS) to investigate functional changes within the tumor microenvironment when treated with different immunotherapy drugs. We injected the CT26 cell line into the flank of 35 mice that were assigned to 4 different groups: anti-PD-1, anti-CTLA-4, combination treatment, and IgG. The 4 groups were injected intraperitoneally on days 1, 4 and 7 (Day 1 – tumor at 80-120 mm3). DRS spectra were acquired simultaneously for 9 consecutive days and a lookup table (LUT)-based inverse model was implemented to decompose the spectral data. We found statistically significant differences in functional changes among the different immunotherapy groups.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.